Program



Day 1 – Friday, 10th May

10:00 Start of Registration

10:45 WELCOME

GLOMERULAR DISEASES

11:00 Discovery of new target antigens in membranous nephropathy and what they mean – Sanjeev Sethi
11:25 Membranous Nephropathy: update on diagnosis and treatment – Fernando Fervenza
11:50 Steroid sparing in ANCA-associated vasculitis – are we there yet? – Ulrich Specks
12:15 Management of proliferative glomerulonephritis with monoclonal immunoglobulin deposits – Fernando Fervenza

12:40 LUNCH BREAK

HYPERTENSION IN SPECIFIC SCENARIOS

13:50 Preeclampsia: old and novel concepts to improve outcome – Vesna Garovic
14:05 Cancer-therapy related hypertension – Sandra Herrmann
14:30 Thrombotic microangiopathies secondary to cancer therapies, infections, etc. – Meera Sridharan
14:55 Management of cardiovascular risk factors in nephrology and oncology – room for improvement? – Neeraj Dhaun

15:20 COFFEE BREAK

THROMBOSIS – FROM BENCH TO BEDSIDE

15:50 Cancer-associated thrombosis: why do we believe that patients require a different approach? – Cihan Ay
16:15 Anticoagulation in our dialysis population: yes, no, maybe? – An S. de Vriese
16:40 Mechanisms of thrombosis in cancer patients – Henri Versteeg
17:05 Bleeding complications and thrombotic events in transplantation – Hatem Amer

19:00 Faculty Dinner

Day 2 – Saturday, 11th May

TRANSPLANTATION

09:00 Imaging Mass Cytometry: applications in native and allograft kidneys – Priya Alexander
09:25 How does sequencing on a single-cell basis inform about prognosis of kidney transplant recipients? – Menna Clatworthy
09:50 Torque Teno virus based immunologic monitoring – Gregor Bond

10:15 COFFEE BREAK

SLE

10:45 Redefining Glucocorticoid Therapy in Lupus Nephritis: Current Evidence and Future Directions – Ali Duarte-Garcia
11:10 Current standard management of LN – Hans-Joachim Anders
11:35 Update in Lupus Nephritis Histopathology – why is it needed? – Ingeborg Bajema
12:00 Complications of SLE medication – Zoster, reduced fertility, fatigue, what else? – Laurent Arnaud

12:30 LUNCH BREAK

FUTURE THERAPIES & COMPLICATIONS OF INNOVATIVE THERAPIES

13:30 BiTE, CiTE, SMITE, TriKE, CART-BiTE, etc. – an overview of new therapeutic options in hematologic malignancies – Dominik Wolf
13:55 CAR-T cell therapy – past, present and future – Fabian Müller
14:20 Hemophagocytic lymphohistiocytosis- an overview – Paul La Rosée
14:45 Amyloidosis – Helen Lachmann

ONCOLOGY AND NEPHROLOGY IN COUNTRIES WITH LOW RESOURCES

15:10 Treating Hematologic Malignancies in a cost-restricted environment – Neil Littleton

15:30 CLOSING REMARKS & END of the Meeting